Ledaga recommended by NICE for rare type of lymphoma

Pharma Times

16 July 2021 - NICE has recommended Recordati Rare Diseases and Helsinn Healthcare’s Ledaga for a type of lymphoma that affects the skin.

Ledaga (chlormethine gel) is recommended for use on the NHS to treat early-stage mycosis fungoides-type cutaneous T-cell lymphoma.

Read Pharma Times article

Michael Wonder

Posted by:

Michael Wonder